North America Gastric Buttons Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Offering (Products and Accessories), Application (Children and Adults), Usage (Enteral Nutrition, Medications, Fluids, and Others), and End User (Hospitals,

North America Gastric Buttons Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Offering (Products and Accessories), Application (Children and Adults), Usage (Enteral Nutrition, Medications, Fluids, and Others), and End User (Hospitals, Clinics, and Others)

The North America gastric buttons market is projected to grow from US$ 185.78 million in 2022 to US$ 289.97 million by 2028; it is estimated to record at a CAGR of 7.7% from 2022 to 2028 .

Increasing Prevalence of Cancer, Neurological Disorders, Diabetes, and Gastrointestinal Diseases Drives Market Growth

Diabetes is a life-threatening chronic disease with no functional cure. It can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes. According to the International Diabetes Federation (IDF), the number of diabetic patients in North America is projected to rise from 46 million in 2017 to 62 million by 2045. The diet of diabetic patients requires enteral nutritional support and diabetes-specific formulas.

Cancer is a leading cause of death worldwide. According to the American Society of Clinical Oncology (ASCO), head and neck cancer accounts for ~4% of all cancers in the US. Maintaining proper nutrition during cancer treatment is essential. When cancer patients struggle with nutrition, physicians opt for gastric buttons to ensure the intake of vitamins, minerals, calories, protein, and fluids in their bodies. Appropriate nutritional intake helps patients fight infection and stay healthy during the treatment, enabling overall healing.

Neurological disorders such as Parkinson's disease, dementia, epilepsy and seizures, autism, cerebral palsy, and Alzheimer's disease affect the brain and nerves of the human body. In the US, the prevalence of neurological disorders is increasing. Alzheimer's disease is a common cause of dementia, characterized by a gradual decline in memory, thinking, behavior, and social skills; these changes affect a person's ability to function. The disease prevalence is expected to increase by ~35% during the forecast period. According to the Alzheimer's Association, 5.7 million people in the Americas had Alzheimer's disease in 2018. According to the Centers for Disease Control and Prevention (CDC), Alzheimer's disease is one of the top 10 leading causes of death in the US. In 2020, the disease affected 5.8 million people in the country. Similarly, according to the Parkinson's Foundation Prevalence Project, ~930,000 individuals with Parkinson's Disease were present in the US in 2020. Epilepsy is a noncommunicable chronic brain disease that affects people of all ages. Almost 80% of people with epilepsy live in low- and middle-income countries. The same source estimates that up to 70% of people with epilepsy could live seizure-free with proper diagnosis and treatment. Weight loss and malnutrition due to suboptimal oral intake are common in patients with neurological disorders and are associated with increased disability, morbidity, and mortality. The nutritional management of patients with these diseases is crucial, and enteral feeding is a commonly used method to provide nutritional support.

Gastrointestinal diseases affect the gastrointestinal (GI) tract. Common GI disorders include irritable bowel syndrome (IBS), acid reflux, indigestion, colon cancer, and hemorrhoids. According to the data published by International Foundation for Gastrointestinal Disorders, ~40% of all IBS patients have a mild condition, ~35% have a moderate condition, and ~25% have a severe condition. Certain factors such as food allergies, developing gastroenteritis stages, sporadic colon movements, colon’s abnormal serotonin composition, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. Pancreatic diseases, liver diseases, and inflammatory bowel diseases (IBDs) are often associated with nutritional difficulties and require adequate nutrition to support medical treatment.

Gastrostomy buttons are used as the enteral route of choice by many doctors. Moreover, they confer a cosmetic advantage as they can be kept hidden under clothing. Once placed, the buttons can be used for several days. With the increasing incidence of chronic diseases in North America, gastrostomy buttons are increasingly being adopted for the administration of food and medicine over the last 5 years .

North America Gastric Buttons Market Overview

The North America gastric buttons market has been segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021. The increasing prevalence of chronic diseases, the rising research and development activities by major healthcare businesses, surging expenditure on patient care, and increasing preference for enteral nutrition drive the growth of the gastric buttons market in North America.

North America Gastric Buttons Market Revenue and Forecast to 2028 (US$ Million)

North America Gastric Buttons Market Segmentation

The North America gastric buttons market is segmented on the basis of offering, application, usage, end user, and country. Based on offering, the market is bifurcated into products and accessories. The products segment held a larger market share in 2022. Further, accessories are categorized as button feeding sets, button decompression sets, and others.

Based on application, the North America gastric buttons market is bifurcated into children and adults. The children segment held a larger market share in 2022.

Based on usage, the North America gastric buttons market is segmented into enteral nutrition, medications, fluids, and others. The enteral nutrition segment held the largest market share in 2022.

Based on end user, the North America gastric buttons market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America gastric buttons market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.

Avanos Medical Inc., Boston Scientific Corp, QMD, Shin-Etsu Polymer Europe BV, Applied Medical Technology Inc., Vygon (UK) Ltd, and Fresenius Kabi AG are the leading companies operating in the North America gastric buttons market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America gastric buttons market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America gastric buttons market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America gastric buttons market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution